Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GameStop Corp. (GME) vs Pfizer Inc (PFE) Price & Performance

GameStop Corp.Trade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

GameStop Corp. vs Pfizer Inc — how do they compare? GameStop Corp. trades at $18.59 (market cap $8.44B), while Pfizer Inc trades at $26.32 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 18× GameStop Corp.'s market cap, and Pfizer Inc pays a 6.46% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals.

GMEPFE
Market Cap
$8.44B$151.73B
Sector
Consumer CyclicalHealth
52-Week High
$27.69$28.56
52-Week Low
$18.79$23.60
Enterprise Value
$4.42B$203.22B
Volume
29,869,932
Dividend Yield
6.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GameStop Corp.

GME trades at $18.57, down 1.2% with bearish technical signals from moving averages. The company shows improving fundamentals with three consecutive quarterly earnings beats and a significant turnaround to profitability, achieving a 20.45% net income margin in 2025. Recent news highlights strategic shifts including potential partnership discussions with eBay instead of a full acquisition. Cash position strengthened to $4.77 billion following a $3.85 billion net cash inflow in 2025.

The outlook remains mixed with strong profitability improvements offset by bearish technical indicators and cautious analyst sentiment. Investment opportunity exists in the company's operational turnaround and cash-rich balance sheet, while risks include potential shareholder dilution from recent debt conversions and ongoing competitive pressures in the retail gaming sector.

Pfizer Inc

Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.

The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.

Read more on GME

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE